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Abstract 62 
Background/Objectives: It is unknown if wine, beer, and spirit intake lead to a similar 63 
association with diabetes. We studied the association between alcoholic beverage preference 64 
and type 2 diabetes incidence in persons who reported to consume alcohol. 65 
Subjects/Methods: Ten European cohort studies from the Consortium on Health and Ageing: 66 
Network of Cohorts in Europe and the United States (CHANCES) were included, comprising 67 
participant data of 62 458 adults who reported alcohol consumption at baseline. Diabetes 68 
incidence was based on documented and/or self-reported diagnosis during follow-up. 69 
Preference was defined as ≥70% of total alcohol consumed was either beer, wine or spirits. 70 
Adjusted hazard ratios (HRs) were computed using Cox proportional hazard regression. 71 
Single cohort HRs were pooled by random-effects meta-analysis. 72 
Results: Beer, wine, or spirit preference was not related to diabetes risk compared with having 73 
no preference. The pooled HRs were HR 1.06 (95%CI 0.93, 1.20) for beer, HR 0.99 (95%CI 74 
0.88, 1.11) for wine, and  HR 1.19 (95%CI 0.97, 1.46) for spirit preference. Absolute wine 75 
intake, adjusted for total alcohol, was associated with a lower diabetes risk: pooled HR per 6 76 
grams/day was 0.96 (95% CI 0.93, 0.99). A spirit preference was related to a higher diabetes 77 
risk in those with a higher BMI, in men and  women separately, but not after excluding 78 
persons with prevalent diseases 79 
Conclusions: This large individual-level meta-analysis among persons who reported alcohol 80 
consumption revealed that the preference for beer, wine, and spirits was similarly associated 81 
with diabetes incidence compared with having no preference.   82 
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Introduction 83 
Diabetes mellitus is the fourth to fifth leading cause of death in most high-income countries1. 84 
In 2014, the International Diabetes Federation estimated the prevalence at 7.9% in Europe1. 85 
Two systematic reviews and meta-analyses, including 20 and 26 cohort studies each, revealed 86 
a non-linear U-shaped relationship between alcohol consumption and type 2 diabetes 87 
incidence in both men and women2, 3. The protective effect of alcohol consumption was 88 
largest with light to moderate consumption. Higher levels of ethanol consumption were not 89 
associated with diabetes or were associated with a higher risk2, 3. On the other hand, a more 90 
recent meta-analysis of 38 studies concluded these risk reductions might have been 91 
overestimated by including less healthy former consumers in the reference group4. Moreover, 92 
the protective association might be confined to women and non-Asian populations only4. 93 
 94 
Further research has indicated that the associations between alcohol and diabetes might be 95 
beverage-specific. A recent systematic review and meta-analysis of 13 prospective studies 96 
showed a strong protective association for wine consumption and type 2 diabetes, while for 97 
beer or spirits only a slight trend of a protective association was observed5. Within the 98 
European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct Study, 99 
moderate alcohol consumption was also related to a lower diabetes risk, in particular the 100 
consumption of red wine6. It was suggested that the association between alcohol and diabetes 101 
was likely to be explained by ethanol itself. Indeed, intervention studies have shown that 102 
alcohol increases levels of HDL-cholesterol, apoliprotein A1, and adiponectin, and reduces 103 
fibrinogen, fasting insulin and HbA1c concentrations7, 8. Hence, the observed differences in 104 
association between wine, beer, and spirits and health outcomes might be due to socio-105 
demographic and lifestyle factors associated with the preference and consumption of these 106 
beverages9, 10. However, differential effects of beer and wine on the glycemic response, as 107 
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expressed by their glycemic index, have also been observed. Beer induces a higher glucose 108 
response than wine, which may be related to the development of diabetes11, 12. Furthermore, 109 
due to its higher polyphenol content, red wine may exert additional benefits including 110 
reduction of blood pressure and inflammation and improving endothelial function13. 111 
 112 
Alcohol consumption is a complex exposure that can be characterized in different ways: the 113 
absolute amount, the drinking frequency, and the beverage type. It is statistically difficult to 114 
distinguish between the overall alcohol effect and the specific effects of beer, wine, and spirits 115 
in observational studies14. We aimed to disentangle beverage-specific effects, independent of 116 
those from the absolute ethanol consumption, by studying the association between alcoholic 117 
beverage consumption and preference and type 2 diabetes incidence. This was done by 118 
performing a meta-analysis of harmonized individual participant data from several European 119 
cohorts including a large proportion of elderly participants. Because this study focused on the 120 
type of alcoholic beverage, the analyses were restricted to persons who reported alcohol 121 
consumption. Moreover, because the consumption of wine, beer, or spirits is mainly 122 
determined by factors including age, sex, socio-economic status, country, and lifestyle, these 123 
variables will be taken as much as possible into account in the analyses to strengthen 124 
potentially causal inference. 125 
 126 
Subjects and methods 127 
Study design and population 128 
The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States 129 
(CHANCES) project is a coordinated multi-country study which aims to harmonize data from 130 
ongoing prospective cohort studies in Europe and the USA in order to produce evidence on 131 
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ageing-related health characteristics and on determinants of healthy ageing among the elderly 132 
in these countries15. 133 
 134 
The CHANCES project includes cohorts from 14 studies across Europe and the USA. In most 135 
CHANCES cohorts, elderly are defined as those who were 60 years or older at recruitment. 136 
The CHANCES project as a whole has received ethical approval by the Hellenic Health 137 
Foundation Committee on Bioethics (HHFCB). In the individual cohorts, all participants 138 
signed informed consent for the original studies.The authors of this study did not have any 139 
access to personal information regarding the participants included in this paper. All data that 140 
have been analyzed are based on the CHANCES harmonized variables and are completely 141 
anonymized. For the present study, the following ten European cohorts were eligible for 142 
analysis: the Zutphen Elderly Study (the Netherlands)16, Rotterdam Study (the Netherlands)17, 143 
the study centers in the Netherlands, Greece, and Sweden from the European Prospective 144 
Investigation into Cancer and Nutrition (EPIC) – Elderly study18, the Tromsø Study 145 
(Norway)19, the Epidemiological Study on Chances for Prevention, Early Detection, and 146 
Optimized THERapy of Chronic Diseases at Old Age (ESTHER) study (Germany)20, and 147 
from the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study, the cohorts 148 
of FINRISK (Finland), Northern Sweden (Sweden), and MOLI-SANI (Italy)21, 22. An 149 
extensive overview of the cohorts included in the CHANCES project and data assessment has 150 
been published elsewhere23. Table 1 displays the main characteristics of the included ten 151 
cohorts and participants. 152 
 153 
Within the cohorts that were eligible for the present study, analyses were conducted upon all 154 
subjects who reported to consume alcohol, without any missing data on alcohol and followed 155 
up for diabetes incidence. Subjects with self-reported or independently ascertained prevalent 156 
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diabetes at baseline or with missing information on prevalent diabetes at baseline were 157 
excluded from analysis. Supplemental Figure 1 shows the participant flow-charts of the ten 158 
included cohorts, comprising a total sample size of 63 458. 159 
 160 
Data assessment and harmonization 161 
Data in the CHANCES project have been collected within the framework of independent 162 
cohort studies, with different protocols for data collection and distinct original research foci. 163 
Data harmonization was a major task of the project and the data harmonization and 164 
conversion rules of the CHANCES project have been described elsewhere23. 165 
 166 
Alcoholic consumption and beverage preference 167 
Baseline alcohol data were recorded either by self-administered or interview-based 168 
questionnaires. The EPIC-Elderly and Rotterdam Study applied a validated food frequency 169 
questionnaire (FFQ)17, 24, 25 to assess alcohol intake. The Zutphen Elderly Study used a 170 
validated dietary history method to assess diet including alcohol16. The Tromsø Study, the 171 
ESTHER study, and MORGAM cohorts derived alcohol consumption from a general 172 
questionnaire. In the FINRISK Study, alcohol consumption during the previous week was 173 
assessed. If not already defined, average daily alcohol consumption in grams was estimated 174 
by adding the amounts of ethanol found in each standard drink or cohort specific size for beer, 175 
wine, and spirits. To ensure comparability across cohorts, a conversion rule was applied using 176 
standardized portion sizes (330 ml for a bottle of beer, 175 ml for a glass of wine, and 25 ml 177 
for a shot of spirit) and alcohol percentages in beer (4.5%), wine (12%), and spirits (37.5%).  178 
 179 
As defined in previous studies, a person was classified as having a preference for beer, wine, 180 
or spirits, when the alcohol consumption from the respective drink comprised 70% or more of 181 
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the total alcohol consumption in grams per day. When the average alcohol consumption from 182 
beer, wine, or spirits did not add up to 70% of the total alcohol consumption, a person was 183 
classified as having no preference26, 27. To assess robustness of this definition, a sensitivity 184 
analysis was performed using a cut-off of 50%. Associations between the preference for beer, 185 
wine, or spirits and diabetes incidence compared to having no specific preference was 186 
assessed. Non-consumers, comprising never and former consumers, were not included in the 187 
analyses.  188 
 189 
Next, the association between average daily intake from beer, wine, and spirits and diabetes 190 
incidence was studied. The absolute intakes of beer, wine, and spirits were adjusted for total 191 
alcohol consumption by the residual method27. In this procedure, intakes of the respective 192 
beverage were regressed upon their total alcohol consumption and the residuals from the 193 
regression were used in the analysis. These residuals represent the differences between each 194 
individual’s actual intake and the intake predicted by their total alcohol consumption. Because 195 
residuals, by definition, have a mean of zero, a constant representing the mean intake in each 196 
population was added to every value to reflect actual consumption values28. The beer, wine, 197 
and spirit residuals are uncorrelated with total alcohol consumption and this allows variation 198 
due to the intake of beer, wine, and spirits to be evaluated directly. The beer, wine, and spirit 199 
residuals were analyzed in tertiles and per 6 g/day. 200 
 201 
Information on drinking patterns, i.e. consumption frequency, was not available for all 202 
cohorts. Sensitivity analyses were performed adjusting the associations additionally for 203 
frequency of consumption (less than once a week, 1-2 days/week, 3-5 days/week, or 6-7 204 
days/week) in the Tromsø Study, ESTHER, and MORGAM.  205 
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Diabetes ascertainment 206 
Diabetes incidence was based on documented or self-reported type 2 diabetes during follow-207 
up or based on fasting glucose measures, depending on the available options within the 208 
cohorts shown in Table 1. 209 
 210 
Covariate assessment 211 
Socio-demographic, lifestyle, and disease history data were assessed by self-administered 212 
questionnaires or in interviews. Weight and height were either measured or self-reported, and 213 
blood samples were drawn to determine total and HDL cholesterol. Diet quality was assessed 214 
with the Healthy Diet Indicator (HDI) as developed by Jankovic et al.29. The HDI score 215 
reflects adherence to the 2003 WHO dietary guidelines. The score ranges from 0 to 70 points 216 
and  includes 6 nutrients (saturated fatty acids, polyunsaturated fatty acids, mono- and 217 
disaccharides, protein, cholesterol, dietary fiber) and 1 food group (fruit and vegetables) of 218 
the 14 WHO guideline goals, which were available for the cohorts providing nutrition data29. 219 
Dietary intake data to calculate the HDI score were available for the Zutphen Elderly Study, 220 
Rotterdam Study, and EPIC-Elderly. Self-reported physical activity was assessed by 221 
questionnaires in the Zutphen Elderly Study, Rotterdam Study, EPIC-Elderly the Netherlands 222 
and Greece, and ESTHER. 223 
 224 
Statistical analysis 225 
The statistical analyses were performed using SAS, version 9.3, software (SAS Institute, Inc., 226 
Cary, North Carolina). Hazard Ratios (HRs) and 95% confidence intervals (CIs) for diabetes 227 
were calculated using Cox proportional hazard regression. The proportional hazard 228 
assumption was tested and not violated. Missing values for any of the covariates were 229 
imputed using the multiple imputation method, in which all variables included in the 230 
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statistical models were included in the procedure. For each cohort, five duplicate datasets 231 
were produced and after statistical inference on the duplicate datasets, pooled estimates were 232 
calculated with PROC MIANALYZE30. In Model 1, HRs were adjusted for socio-233 
demographic factors: age (continuous; years), gender (not applicable for the Zutphen Elderly 234 
Study, which is composed only of men), education (categorical: primary or less (low), more 235 
than primary but less than college or university (middle), college or university (high)), 236 
employment status (categorical: full-time or part-time employment and not of pensionable 237 
age, self-employed, housewife and not of pensionable age, pensionable age and still working, 238 
pensionable age and not working, stopped work before retirement age due to poor health, 239 
unemployed and not of pensionable age; not applicable for SENECA and the Zutphen Elderly 240 
Study, where only retired subjects are included), and prevalent coronary heart disease (CHD; 241 
yes/no) or cancer (yes/no). Model 2 was additionally adjusted for the lifestyle factors: 242 
smoking status (categorical: never, former, current), sports activity (continuous: hours per 243 
week; physical activity data were not available for EPIC-Elderly Sweden, the Tromsø Study, 244 
and MORGAM; total physical activity was used in the Rotterdam Study), and HDI-score 245 
(continuous; dietary intake data to generate the HDI score was not available for ESTHER, the 246 
Tromsø Study, and MORGAM).  247 
 248 
Because the definition of alcoholic beverage preference is not based upon absolute alcohol 249 
consumption, persons with a beer preference might, for instance, have a higher absolute 250 
alcohol intake than persons with a wine preference. Thus, total alcohol consumption might be 251 
a confounding factor. Due to the U-shaped relationship between total alcohol and diabetes2,3, 252 
additional adjustment for absolute alcohol consumption (gram/day) was evaluated using 253 
fractional polynomials where the best fit regression model was selected with the SAS Macro 254 
“Multivariable Fractional Polynomials”31. This macro uses an algorithm to determines the 255 
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inclusion and transformation of continuous covariates while taking into account their non-256 
linearity. In a stepwise approach, the algorithm constructs a fractional polynomial 257 
transformation for the continuous covariate. Backward elimination selects the best 258 
transformation of the covariate, e.g. linear, first degree or second degree. Depending on the P-259 
values associated with the best transformations, covariates may be eliminated from the model. 260 
In all cohorts, absolute alcohol consumption was omitted from the best fit model. Because the 261 
residuals of beer, wine, and spirit consumption are uncorrelated with total alcohol intake, 262 
these HR were not adjusted for total alcohol.  263 
 264 
Adjustment model 3 was additionally adjusted for BMI (linearly or second degree; kg/m2); 265 
this adjustment for BMI was also evaluated using fractional polynomials. BMI was omitted 266 
from the best fit model in the Zutphen Elderly Study, included as a second degree variable in 267 
ESTHER and FINRISK, and included linearly in the remaining cohorts. BMI is one of the 268 
most important risk factors for diabetes, but is also on a possible causal pathway between 269 
alcohol consumption and diabetes. Therefore, crude and adjusted BMI across alcoholic 270 
beverage preference categories was estimated with multiple linear regression. To investigate 271 
effect modification by BMI, stratified analyses were performed on persons with a BMI <25 272 
and ≥25 kg/m2 and the P-value for interaction was checked after including a product term in 273 
the regression models. Furthermore, stratified analyses were performed for men and women 274 
separately to check for potential effect modification. Finally, subjects with prevalent CHD or 275 
cancer at baseline or a follow-up less than 2 years were excluded in a sensitivity analysis. 276 
 277 
Cohort-specific HR estimates and 95% CIs for diabetes incidence from having a beer, wine, 278 
or spirit preference compared with no preference and for a beer, wine, or spirit consumption 279 
(per 6 gram/day) were pooled in meta-analyses, using adjustment model 3. Inverse variance 280 
13 
 
weighting was applied to give the largest weight to the study with the lowest variance. The 281 
random-effects model takes into account the between-study variance and the within-study 282 
variance. Heterogeneity between studies was assessed by the Q statistic and the I2 index. I2 283 
was calculated as I2 = ((Q – df)/Q)*100, where “df” stands for degrees of freedom, i.e. total 284 
number of studies (k) minus 1. Random-effects meta-analyses with inverse variance 285 
weighting were performed using the R package “meta” (R version 3.3.1). Statistical tests were 286 
two-sided and P-values <0.05 were considered statistically significant. 287 
 288 
Results 289 
In most cohorts, persons with a wine preference constituted the largest group, ranging from 290 
44% in ESTHER (Germany) to 79% in MOLI-SANI (Italy) (Supplemental Table 1). In 291 
EPIC-Elderly Sweden, the Tromsø Study, FINRISK, and Northern-Sweden persons with no 292 
preference formed the largest group and in the Zutphen Elderly Study (the Netherlands), 293 
persons with a spirit preference comprised the largest group, i.e. 62%.  Across all cohorts, 294 
those who preferred wine were relatively more highly educated and were more likely to be a 295 
never smoker, and female. Furthermore, those with a beer or spirit preference were more 296 
likely to be male and current smoker. Persons with no specific preference generally had the 297 
highest absolute alcohol consumption. After adjustment for age, sex, education, employment, 298 
prevalent diseases, smoking, alcohol, sports activity, diet, BMI was lowest among those with 299 
a beer or wine preference and BMI was highest among persons with a spirit preference 300 
(Supplemental Table 1). 301 
 302 
The pooled HRs from the random-effects meta-analyses showed no significant association 303 
between having a preference for beer, wine, or spirits and diabetes incidence compared with 304 
having no specific preference after adjustment for age, sex, education, prevalent diseases, 305 
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lifestyle factors, and BMI (Figure 1-3). Pooled HR was 1.06 (95%CI 0.93, 1.20) for a beer 306 
preference, HR 0.99 (95%CI 0.88, 1.11) for a wine preference, and HR 1.19 (95%CI 0.97, 307 
1.46) for having a spirit preference. Based on the I2 index and the Q-statistic, between-study 308 
heterogeneity was observed for the effect estimates of having a spirit preference.  309 
 310 
Separate HRs and 95% CIs for the associations between a beer, wine, or spirits and diabetes 311 
incidence according to the different levels of adjustment are shown in Supplemental Table 1. 312 
Compared with persons with no preference, a preference for beer, wine, or spirits was in most 313 
cohorts not significantly associated with diabetes incidence. In the Rotterdam Study, beer or 314 
spirit preference had a significant association with a higher diabetes incidence. In EPIC-315 
Elderly Greece, having a wine preference tended to be associated with a lower diabetes 316 
incidence. Within the cohorts, additional adjustment for BMI (Model 3) had mixed, but small 317 
effects on the observed associations. 318 
 319 
The pooled HR for the association between alcohol preference and incident diabetes among 320 
sub-groups and with additional adjustments are shown in Table 2. Diabetes risk among 321 
persons with a spirit preference was higher in those with a higher BMI, in men and in women, 322 
but not after excluding persons with prevalent diseases. Excluding persons with prevalent 323 
diseases yielded similar results to the findings including those persons. P-values for 324 
interaction by BMI were not significant for all cohorts and did not therefore give indication 325 
for effect modification. Furthermore, additional adjustment for consumption frequency and 326 
alternative analysis using 50% as a cut-off in the definition of preference showed similar 327 
associations.  328 
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Additionally, the association between the residuals of beer, wine, and spirit intake per 6 329 
gram/day and diabetes incidence was assessed (Figure 4-6). Pooled HR was 1.03 (95%CI 330 
0.99, 1.06)  per 6 grams of beer intake, HR 0.96 (95%CI 0.93, 0.99) per 6 grams of wine 331 
intake, and HR 1.02 (95%CI 0.98, 1.06) per 6 grams of spirit intake. Cohort-specific HR 332 
according to tertiles and per 6 grams/day generally showed similar associations 333 
(Supplemental Table 2).   334 
 335 
Discussion 336 
This meta-analysis of individual participant data from ten prospective European cohorts 337 
comprising ~60,000 adults who reported at least some alcohol consumption showed that a 338 
preference for beer, wine or spirits was not associated with a lower or higher diabetes risk 339 
compared with having no specific preference, taking into account several socio-demographic 340 
and lifestyle variables.  341 
 342 
To our knowledge, no other studies have investigated the association between alcoholic 343 
beverage preference and diabetes risk. However, a number of observational studies have 344 
assessed associations of absolute beverage-specific consumption and diabetes, showing 345 
inconsistent results. Among 36,527 Australian adults, Hodge et al. observed an inverse 346 
association between wine consumption and risk of type 2 diabetes, but not for beer or spirits32. 347 
In the EPIC-InterAct Study, a prospective case-cohort study of 16,154 participants and 12,403 348 
incident diabetes cases, consumption of wine and fortified wine were most strongly related 349 
with a reduced diabetes risk6. Moreover, compared with a light consumption, men who did 350 
not consume beer had a reduced risk of diabetes in the EPIC-InterAct Study: HR 0.84 (95%CI 351 
0.74, 0.95) and in women higher spirit consumption was associated with an higher diabetes 352 
risk (P-trend 0.044). Fagherazzi et al. observed an inverse association between wine 353 
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consumption and diabetes risk when compared to other types of alcoholic beverage among 354 
66,485 women from the French E3N-EPIC cohort33. In contrast, Conigrave et al., did not find 355 
a protective effect of red wine on diabetes risk among 46,892 U.S. male health professionals, 356 
whereas inverse associations for beer, spirits and white wine were similar and independent34. 357 
Moreover, two other studies in large U.S. cohorts also did not observe a specific protective 358 
effect of wine consumption on diabetes risk compared with beer or spirit consumption35, 36. In 359 
their meta-analysis of 13 prospective studies, Huang, Wang, and Zhang presented a pooled 360 
RR of 0.85 (95% CI 0.80-0.89) for wine consumption, and RR 0.96 (95% CI 0.92, 1.00) for 361 
beer consumption and RR 0.95 (95%CI 0.89-1.03) for spirit consumption and type 2 diabetes 362 
risk compared to no or rare alcohol consumption5. In the present study, the pooled HR for 363 
residuals of beer, wine, and spirit intake showed similar results: a higher wine intake was 364 
related to a lower diabetes risk, even after fully taking into account total alcohol consumption. 365 
This further confirms the consistent finding that constituents other than ethanol in red wine 366 
may exert additional health benefits13. 367 
 368 
Several other studies have found differential effects for the type of alcoholic beverage and 369 
diabetes risk, with a stronger beneficial association for wine consumption compared to 370 
abstinence. These observations could either be explained by a true beneficial effect of wine 371 
compared with beer and spirits, or by an artefact arising from residual confounding. Firstly, a 372 
true differential effect for beer, wine, and spirits and diabetes incidence might be caused by 373 
beneficial compounds other than ethanol in particular those found in wine. For example, a 374 
randomized controlled cross-over trial in 67 men at high cardiovascular risk showed that red 375 
wine rich in polyphenols with or without alcohol improved glucose metabolism37. This was 376 
not confirmed in our study, where we have found no additional beneficial association for 377 
having a wine preference compared to having no preference. Secondly, the observation might 378 
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be an artefact caused by confounding factors associated with the type of alcoholic beverage 379 
consumed. Indeed, the choice of alcoholic beverage is associated with a wide range of 380 
cultural, socio-demographic and lifestyle factors9, 38, which may confound the association 381 
between alcohol and diabetes risk. Moreover, other important determinants of diabetes risk 382 
including age, gender, smoking status and overall drinking patterns differ across alcoholic 383 
beverage preference and study populations10. Therefore, we have adjusted the associations for 384 
age, gender, socio-economic status, and lifestyle factors including absolute alcohol 385 
consumption and BMI. However, we cannot exclude any residual confounding as a result of 386 
unmeasured or imprecisely measured confounders. Lastly, in previous studies there is a 387 
tendency to find an association for the alcoholic beverage that is most consumed. In the above 388 
mentioned studies into beverage type and diabetes risk, most of the alcohol was consumed as 389 
wine6, 32, 33. In our study, ten cohorts from seven European countries were included with 390 
varying preferences, suggesting this might have less influence on our findings and provided a 391 
wider insight into alcohol preference across Europe.  392 
 393 
We observed a tendency toward a higher diabetes risk among persons with a spirit preference 394 
compared to those having no specific preference among men and women when analyzed 395 
separately and those with a higher BMI. This was also seen within EPIC-InterAct6. Cross-396 
sectional studies have shown that a spirit preference is associated with an unhealthier lifestyle: 397 
persons who preferred spirits have been shown to have a higher BMI, are more likely to be 398 
smokers, and display unhealthier diet. Furthermore, spirits may be more often used for heavy 399 
binge drinking compared to wine9, 10. In the present study, we could only take consumption 400 
frequency into account in a subset of five cohorts. Furthermore, the association was attenuated 401 
when excluding persons with prevalent diseases or a short follow-up, indicating that some 402 
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degree of reverse causation might be present. Finally, we were not able to take diet and 403 
physical activity into account in all cohorts. 404 
 405 
To avoid any bias by the inclusion of former drinkers, the current analysis was restricted to 406 
persons who reported some alcohol consumption. Furthermore, persons with no specific 407 
preference, i.e. mixed drinkers, were used as a reference. Most other observational studies 408 
have used non-consumers as a reference; however, this has been contested. Non-consumers 409 
are in general a heterogeneous group comprising lifetime abstainers and former drinkers. In 410 
many high-income countries, lifetime abstinence of alcohol is not normative and this group 411 
differs from alcohol consumers in other health determinants39. Moreover, former drinkers may 412 
have quit because of ill health arising from their former (heavy) alcohol use. As a result, these 413 
individuals are more vulnerable for morbidity and mortality and their ill health may confound 414 
the association between alcohol consumption and health outcomes. Using non-consumers as a 415 
reference group may overestimate the beneficial effects of alcohol40. On the other hand, in the 416 
meta-analysis of Di Castelnuovo et al., there was still a protective effect of alcohol 417 
consumption in the general population after exclusion of former drinkers41. We were unable 418 
to take into account former alcohol consumption in all cohorts, but by restricting the analyses 419 
to alcohol consumers, possible confounding by abstinence or former alcohol consumption 420 
could not influence our results. 421 
 422 
The association between alcoholic beverage preference and diabetes may be partly driven by 423 
obesity: since adiposity is on one causal pathway between absolute alcohol consumption and 424 
diabetes, adjusting for BMI may lead to overadjustment bias42. However, after multiple 425 
adjustments, those with a spirit preference had the highest BMI and persons with a beer or 426 
wine preference had the lowest BMI. Because BMI is a strong risk factor for developing 427 
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diabetes, the effect of moderate alcohol consumption might be strongest, in absolute terms, in 428 
those at higher risk. In our analysis,  the association between spirit preference and diabetes 429 
incidence was higher among those with overweight or obese (BMI>25 kg/m2). In contrast, 430 
Beulens et al. found that moderate alcohol consumption was more strongly related to a 431 
reduced diabetes risk in overweight men and women than in their normal weight 432 
counterparts6. Moreover, in the French E3N-EPIC cohort, overweight women consuming two 433 
or more glasses of wine per day had a lower diabetes risk, whereas in normal weight women 434 
consuming the same amount, no association was observed33.  435 
 436 
We aimed to disentangle beverage-specific effects, independent of those from the absolute 437 
ethanol consumption, by studying the association between alcoholic beverage preference and 438 
type 2 diabetes incidence. Beverage preference was used to classify the study population 439 
according to their alcohol intake. This approach of studying preference rather than absolute 440 
intake can thus be considered as a qualitative approach. Independent from the biological 441 
mechanisms associated with the chemical composition of the beverages, beverage preference 442 
per se may not be directly associated with diabetes incidence. Therefore, we have additionally 443 
studied the residuals of beer, wine and spirit intake, fully adjusted for total alcohol 444 
consumption by the residual method28; these analyses yielded similar findings. The number of 445 
cases distributed by beverage preference differed across the cohorts and were in some cohorts 446 
quite low, which may have affected the statistical power of the analyses. Non-consumers were 447 
excluded from the analysis to prevent non-consumers and former (heavy) consumers to affect 448 
the results. As a result, these findings only apply to alcohol consumers.  449 
 450 
The CHANCES project is a large-scale multi-national collaboration of cohort studies 451 
including a large number of elderly persons. Pooled analyses of the individual participant data 452 
20 
 
from the different cohorts is a cost-efficient analytical approach and increases statistical 453 
power considerably. However, we had to rely on secondary data collected according to 454 
different study objectives and protocols, which may be a weakness15. With respect to type 2 455 
diabetes incidence, the identification and verification of diabetes cases varied across the 456 
cohorts. The oral glucose tolerance test is considered the gold standard of diabetes 457 
ascertainment, but recently fasting glucose has been shown to be the most accurate method of 458 
diabetes diagnosis43. Most cohort studies relied on self-reports, linkage with registries, HbA1c, 459 
or fasting blood glucose measures. As a result, misclassification could have been present and 460 
we might have underestimated the number of diabetes cases. However, only if this 461 
misclassification is differential and related to alcohol preference, would it have influenced the 462 
direction of the effect estimates, and yet our observed associations across cohorts were 463 
broadly consistent. Furthermore, it is difficult to distinguish between type 1 and type 2 464 
diabetes; therefore, some cohorts may not have been able to appropriately distinguish between 465 
the types. Moreover, this issue is not restricted to this study only. Diagnosing diabetes can be 466 
equivocal: the clinical diagnosis is based on a pre-specified cut-off point on a continuous 467 
scale of declining glycemic control, but clinical practice will dictate how assiduously the 468 
necessary tests are applied. Furthermore, the diagnosis is often based on the occurrence of 469 
complications of the disease and the disease can remain asymptomatic for years. Hence, it has 470 
been estimated that up to 50% of all type 2 diabetes patients are undiagnosed44. As a result, 471 
the true association may have been underestimated. 472 
 473 
This meta-analysis of individual participant data from ten cohorts among Europeans who 474 
reported at least some alcohol consumption showed that beer, wine, and spirits were similarly 475 
associated with diabetes incidence. The recommendations of the American Diabetes 476 
Association for the prevention of diabetes suggest that if adults choose to drink alcohol, daily 477 
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intake should be limited to a moderate amount, i.e. no more than one drink per day for women 478 
and two drinks per day for men45. Our analysis offers little support for making beverage 479 
specific recommendation for diabetes prevention.  480 
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Figure legends: 684 
 685 
Figure 1. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) 686 
for the association between beer preference and diabetes incidence compared to having no 687 
preference adjusted for age, sex, education, employment status, prevalent coronary heart 688 
disease and cancer, smoking status, physical activity (if available), Healthy Diet Indicator 689 
score (if available), and BMI. 690 
 691 
Figure 2. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) 692 
for the association between wine preference and diabetes incidence compared to having no 693 
preference adjusted for age, sex, education, employment status, prevalent coronary heart 694 
disease and cancer, smoking status, physical activity (if available), Healthy Diet Indicator 695 
score (if available), and BMI. 696 
 697 
Figure 3. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) 698 
for the association between spirit preference and diabetes incidence compared to having no 699 
preference adjusted for age, sex, education, employment status, prevalent coronary heart 700 
disease and cancer, smoking status, physical activity (if available), Healthy Diet Indicator 701 
score (if available),  and BMI. 702 
 703 
Figure 4. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) 704 
for the association between residuals of beer consumption per 6 g/d and diabetes incidence 705 
adjusted for absolute alcohol intake, age, sex, education, employment status, prevalent 706 
coronary heart disease and cancer, smoking status, physical activity (if available), Healthy 707 
Diet Indicator score (if available), and BMI. 708 
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Figure 5. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) 709 
for the association between residuals of wine consumption per 6 g/d and diabetes incidence 710 
adjusted for absolute alcohol intake, age, sex, education, employment status, prevalent 711 
coronary heart disease and cancer, smoking status, physical activity (if available), Healthy 712 
Diet Indicator score (if available), and BMI. 713 
Figure 6. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) 714 
for the association between residuals of spirit consumption per 6 g/d and diabetes incidence 715 
adjusted for absolute alcohol intake, age, sex, education, employment status, prevalent 716 
coronary heart disease and cancer, smoking status, physical activity (if available), Healthy 717 
Diet Indicator score (if available), and BMI. 718 
Figure 1. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between beer preference and 
diabetes incidence compared to having no preference adjusted for age, sex, education, employment status, prevalent coronary heart disease and 
cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
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EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
MORGAM: MOLI‐SANI, Italy 
Combined – Random Effects Model 
Q=12.14 (P‐value: 0.21); I2:26% (0%‐64%) 
 
 
1.60 (0.55‐4.63) 
1.49 (0.99‐2.24) 
1.14 (0.72‐1.80) 
0.82 (0.70‐0.95) 
1.00 (0.53‐1.87) 
1.03 (0.73‐1.44) 
0.96 (0.76‐1.20) 
0.94 (0.80‐1.10) 
1.15 (0.69‐1.93) 
1.22 (0.83‐1.80) 
0.99 (0.88‐1.11) 
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Figure 1. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between beer preference and 
diabetes incidence compared to having no preference adjusted for age, sex, education, employment status, prevalent coronary heart disease and 
cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
Study  Hazard Ratio  HR (95% CI)  %W(random) 
 
Zutphen Elderly Study, the Netherlands 
Rotterdam Elderly Study, the Netherlands 
EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
MORGAM: MOLI‐SANI, Italy 
Combined – Random Effects Model 
Q=12.08 (P‐value: 0.21); I2: 26% (0%‐64%) 
 
 
1.00 (0.31‐3.27) 
2.21 (1.33‐3.68) 
0.91 (0.30‐2.74) 
0.92 (0.71‐1.19) 
0.81 (0.52‐1.26) 
1.23 (0.86‐1.77) 
0.98 (0.78‐1.24) 
1.05 (0.93‐1.18) 
1.06 (0.72‐1.56) 
1.29 (0.63‐2.65) 
1.06 (0.93‐1.20) 
 
1.1 
5.4 
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15.3 
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17.9 
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Figure 2. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between wine preference and 
diabetes incidence compared to having no preference adjusted for age, sex, education, employment status, prevalent coronary heart disease and 
cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
Study  Hazard Ratio  HR (95% CI)  %W (random) 
 
Zutphen Elderly Study, the Netherlands 
Rotterdam Elderly Study, the Netherlands 
EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
MORGAM: MOLI‐SANI, Italy 
Combined – Random Effects Model 
Q=12.14 (P‐value: 0.21); I2:26% (0%‐64%) 
 
 
1.60 (0.55‐4.63) 
1.49 (0.99‐2.24) 
1.14 (0.72‐1.80) 
0.82 (0.70‐0.95) 
1.00 (0.53‐1.87) 
1.03 (0.73‐1.44) 
0.96 (0.76‐1.20) 
0.94 (0.80‐1.10) 
1.15 (0.69‐1.93) 
1.22 (0.83‐1.80) 
0.99 (0.88‐1.11) 
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24.1 
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16.0 
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Figure 3. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between spirit preference and 
diabetes incidence compared to having no preference adjusted for age, sex, education, employment status, prevalent coronary heart disease and 
cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
Study  Hazard Ratio  HR (95% CI)  %W (random) 
 
Zutphen Elderly Study, the Netherlands 
Rotterdam Elderly Study, the Netherlands 
EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
Combined – Random Effects Model 
Q=17.47 (P‐value: 0.03); I2:54% (3%‐78%) 
 
 
1.60 (0.55‐4.63) 
1.49 (0.99‐2.24) 
1.14 (0.72‐1.80) 
0.82 (0.70‐0.95) 
1.00 (0.53‐1.87) 
1.03 (0.73‐1.44) 
0.96 (0.76‐1.20) 
0.94 (0.80‐1.10) 
1.15 (0.69‐1.93) 
1.19 (0.97‐1.46) 
 
3.9 
12.5 
8.3 
17.0 
5.8 
15.4 
8.7 
23.2 
5.3 
 
Figure 4. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between the residuals of beer 
consumption per 6 g/d and diabetes incidence adjusted for absolute alcohol intake, age, sex, education, employment status, prevalent coronary 
heart disease and cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
Study  Hazard Ratio  HR (95% CI)  %W(random) 
 
Zutphen Elderly Study, the Netherlands 
Rotterdam Elderly Study, the Netherlands 
EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
MORGAM: MOLI‐SANI, Italy 
Combined – Random Effects Model 
Q=5.17 (P‐value: 0.82); I2: 0% (0%‐35%)   
 
0.97 (0.77‐1.21) 
0.97 (0.87‐1.09) 
1.13 (0.89‐1.44) 
1.03 (0.95‐1.12) 
1.20 (0.56‐2.56) 
1.16 (0.95‐1.41) 
1.05 (0.95‐1.16) 
1.02 (0.98‐1.07) 
1.49 (0.86‐2.60) 
1.01 (0.90‐1.14) 
1.03 (0.99‐1.06) 
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14.9 
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52.7 
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Figure 5. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between the residuals of wine 
consumption per 6 g/d and diabetes incidence adjusted for absolute alcohol intake, age, sex, education, employment status, prevalent coronary 
heart disease and cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
Study  Hazard Ratio  HR (95% CI)  %W(random) 
 
Zutphen Elderly Study, the Netherlands 
Rotterdam Elderly Study, the Netherlands 
EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
MORGAM: MOLI‐SANI, Italy 
Combined – Random Effects Model 
Q=5.80 (P‐value: 0.76); I2: 0% (0%‐42%) 
 
 
0.84 (0.59‐1.21) 
0.92 (0.82‐1.04) 
0.90 (0.78‐1.04) 
0.95 (0.90‐1.01) 
0.44 (0.17‐1.10) 
0.91 (0.73‐1.15) 
0.96 (0.87‐1.07) 
0.98 (0.92‐1.04) 
0.98 (0.49‐1.96) 
1.00 (0.89‐1.12) 
0.96 (0.93‐0.99) 
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Figure 6. Forest plot with pooled Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for the association between the residuals of spirit 
consumption per 6 g/d and diabetes incidence adjusted for absolute alcohol intake, age, sex, education, employment status, prevalent coronary 
heart disease and cancer, smoking status, physical activity (if available), Healthy Diet Indicator score (if available), and BMI. 
Study  Hazard Ratio  HR (95% CI)  %W(random) 
 
Zutphen Elderly Study, the Netherlands 
Rotterdam Elderly Study, the Netherlands 
EPIC‐Elderly, the Netherlands 
EPIC‐Elderly, Greece 
EPIC‐Elderly, Sweden 
The Tromsø Study, Norway 
ESTHER, Germany 
MORGAM: FINRISK, Finland 
MORGAM: Northern‐Sweden, Sweden 
MORGAM: MOLI‐SANI, Italy 
Combined – Random Effects Model 
Q=9.89 (P‐value: 0.36); I2: 9% (0%‐66%)   
 
1.08 (0.90‐1.31) 
1.07 (0.98‐1.17) 
1.08 (0.93‐1.26) 
1.05 (0.99‐1.11) 
1.65 (0.74‐3.68) 
0.84 (0.57‐1.25) 
0.93 (0.64‐1.35) 
0.99 (0.94‐1.03) 
0.51 (0.21‐1.26) 
0.93 (0.69‐1.26) 
1.02 (0.98‐1.06) 
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Supplemental Figure 1: Participant flow-charts of the ten included European cohort studies 
from the Consortium on Health and Ageing: Network of Cohorts in Europe and the United 
States (CHANCES) project. 
 
 
Supplemental Table 1. Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) and 95% 
Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to having no 
preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
Zutphen Elderly Study     
N (%) 65 (12) 73 (13) 344 (62) 75 (13) 
Age, years 70.5 (5.8) 72.1 (5.0) 72.2 (5.2) 71.8 (5.5) 
Men, % 100 100 100 100 
Ethanol consumption, g/day 13.5 [4.0-25.0] 3.8 [1.7-12.0] 18.8 [6.2-37.5 20.3 [8.4-44.9 
University or college education, % 0 14 3 10 
Current smokers, % 32 23 41 29 
BMI, kg/m2     
- Crude 26.0 (0.4) 24.7 (0.4)* 25.5 (0.2) 25.3 (0.4) 
- Adjusteda 25.9 (0.4) 25.0 (0.4) 25.5 (0.2) 25.3 (0.4) 
Diabetes cases / Person Years 6 / 756 9 / 747 27 / 3529 6 / 848 
HR (95% CI): Model 1 1.00 (0.32-3.18) 1.34 (0.46-3.89) 0.95 (0.39-2.32) 1.00 (ref) 
HR (95% CI): Model 2 1.04 (0.32-4.15) 1.46 (0.52-4.15) 0.96 (0.38-2.42) 1.00 (ref) 
HR (95% CI): Model 3 1.00 (0.31-3.27) 1.60 (0.55-4.63) 1.07 (0.42-2.77) 1.00 (ref) 
     
Rotterdam Study     
N (%) 182 (7) 1292 (53) 582 (24) 372 (15) 
Age, years 62.4 (5.8) 64.8 (6.8) 66.2 (6.5) 64.0 (6.1) 
  
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
Men, % 88 17 72 71 
Ethanol consumption, g/day 11.7 [3.0-25.7] 2.9 [0.6-9.1] 18.9 [7.5-31.8] 11.3 [3.6-24.9] 
University or college education, % 13 8 11 18 
Current smokers, % 31 17 28 22 
BMI, kg/m2     
- Crude 25.4 (0.3) 26.1 (0.1)* 26.2 (0.1)* 25.7 (0.2)**,*** 
- Adjusteda 25.6 (0.3) 26.0 (0.1) 26.4 (0.2)*,** 26.0 (0.2)*** 
Diabetes cases / Person Years 30 / 1756 155 / 13447 100 / 5321 32 / 3920 
HR (95% CI): Model 1 2.10 (1.27-3.47) 1.43 (0.96-2.15) 2.30 (1.54-3.43) 1.00 (ref) 
HR (95% CI): Model 2 2.15 (1.29-3.57) 1.48 (0.98-2.24) 2.38 (1.58-3.57) 1.00 (ref) 
HR (95% CI): Model 3 2.21 (1.33-3.68) 1.49 (0.99-2.24) 2.28 (1.52-3.43) 1.00 (ref) 
     
EPIC-Elderly the Netherlands    
N (%) 82 (2) 2802 (74) 384 (10) 525 (14) 
Age, years 63.7 (2.6) 64.2 (2.7) 64.1 (2.5) 64.2 (2.7) 
Men, %  39 2 13 12 
Ethanol consumption, g/day 7.3 [1.3-20.1] 4.4 [1.3-13.1] 10.1 [1.8-25.7] 4.9 [1.5-12.8] 
University or college education, % 7 16 8 12 
Current smokers, % 40 15 29 17 
  
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
BMI, kg/m2     
- Crude 25.2 (0.4) 25.5 (0.1) 26.4 (0.2)*,** 25.6 (0.2)*** 
- Adjusteda 25.0 (0.4) 25.7 (0.1) 26.3 (0.2)*,** 25.6 (0.2)*** 
Diabetes cases / Person Years 4 / 416 167 / 13601 26 / 1927 22 / 2559 
HR (95% CI): Model 1 0.75 (0.25-2.22) 1.28 (0.81-2.02) 1.22 (0.69-2.17) 1.00 (ref) 
HR (95% CI): Model 2 0.88 (0.29-2.57) 1.23 (0.78-1.94) 1.20 (0.67-2.13) 1.00 (ref) 
HR (95% CI): Model 3 0.91 (0.30-2.74) 1.14 (0.72-1.80) 1.11 (0.63-1.98) 1.00 (ref) 
     
EPIC-Elderly Greece     
N (%) 510 (10) 2561 (48) 361 (7) 1884 (35) 
Age, years 66.2 (4.5) 67.4 (4.5) 67.0 (4.3) 66.3 (4.3) 
Men, % 47 46 74 52 
Ethanol consumption, g/day 1.3 [0.6-8.5] 8.0 [1.2-16.0] 13.2 [4.4-21.3] 2.8 [1.3-12.5] 
University or college education, % 4 2 3 7 
Current smokers, % 12 13 29 16 
BMI, kg/m2     
- Crude 29.2 (0.2) 28.9 (0.1) 28.9 (0.2) 28.8 (0.1) 
- Adjusteda 29.0 (0.2) 28.7 (0.1) 29.4 (0.2)** 29.0 (0.1) 
Diabetes cases / Person Years 72 / 5407 377 / 28107 58 / 3717 308 / 20618 
HR (95% CI): Model 1 0.99 (0.77-1.28) 0.78 (0.67-0.91) 1.37 (1.03-1.82) 1.00 (ref) 
 
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
HR (95% CI): Model 2 0.98 (0.76-1.27) 0.80 (0.69-0.94) 1.32 (1.00-1.76) 1.00 (ref) 
HR (95% CI): Model 3 0.92 (0.71-1.19) 0.82 (0.70-0.95) 1.27 (0.95-1.68) 1.00 (ref) 
     
EPIC-Elderly Sweden     
N (%) 958 (34) 413 (15) 137 (5) 1311 (47) 
Age, years 60.4 (1.3) 60.3 (0.9) 60.4 (1.2) 60.3 (0.8) 
Men, % 58 15 77 54 
Ethanol consumption, g/day 0.9 [0.3-2.7] 1.6 [0.1-3.3] 2.0 [0.2-2.4] 2.9 [0.4-5.4] 
University or college education, % 11 18 5 13 
Current smokers, % 13 13 40 22 
BMI, kg/m2     
- Crude 25.6 (0.1) 25.5 (0.2) 26.7 (0.3)*,** 25.9 (0.1)*** 
- Adjusteda 25.5 (0.1) 25.5 (0.2) 26.8 (0.3)*,** 26.0 (0.1)*,*** 
Diabetes cases / Person Years 33 / 12680 14 / 5406 9 / 1821 53 / 17276 
HR (95% CI): Model 1 0.81 (0.52-1.25) 1.00 (0.54-1.86) 1.34 (0.65-2.74) 1.00 (ref) 
HR (95% CI): Model 2 0.80 (0.52-1.25) 1.00 (0.53-1.86) 1.31 (0.63-2.81) 1.00 (ref) 
HR (95% CI): Model 3 0.81 (0.52-1.26) 1.00 (0.53-1.87) 0.92 (0.44-1.93) 1.00 (ref) 
     
The Tromsø Study     
N (%) 722 (15) 1502 (30) 1042 (21) 1692 (34) 
 
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
Age, years 59.6 (8.4) 59.8 (8.8) 62.1 (8.6) 58.7 (7.7) 
Men, % 76 28 74 71 
Ethanol consumption, g/day 3.3 [1.7-6.1] 4.7 [2.4-7.1] 1.1 [1.1-2.6] 4.7 [2.8-8.1] 
University or college education, % 18 33 10 28 
Current smokers, % 38 29 50 34 
BMI, kg/m2     
- Crude 25.4 (0.1) 25.4 (0.1) 25.9 (0.1)*,** 25.9 (0.1)*,** 
- Adjusteda 25.3 (0.1) 25.6 (0.1) 25.9 (0.1)*,** 25.8 (0.1)** 
Diabetes cases / Person Years 45 / 9158 65 / 19853 72 / 12715 96 / 22094 
HR (95% CI): Model 1 1.12 (0.78-1.60) 0.95 (0.68-1.34) 1.32 (0.96-1.81) 1.00 (ref) 
HR (95% CI): Model 2 1.12 (0.78-1.60) 0.96 (0.68-1.34) 1.32 (0.96-1.81) 1.00 (ref) 
HR (95% CI): Model 3 1.23 (0.86-1.77) 1.03 (0.73-1.44) 1.17 (0.85-1.61) 1.00 (ref) 
     
ESTHER     
N (%) 1466 (28) 2305 (44) 107 (2) 1408 (27) 
Age, years 61.5 (6.4) 61.5 (6.6) 63.2 (6.8) 62.0 (6.6) 
Men, % 77 32 22 64 
Ethanol consumption, g/day 6.6 [2.6-13.2] 5.6 [3.7-11.0] 0.8 [0.8-2.5] 9.1 [5.3-15.8] 
Middle education, % 21 35 25 34 
Current smokers, % 26 13 13 14 
 
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
BMI, kg/m2     
- Crude 27.6 (0.1) 26.8 (0.1)* 28.0 (0.4)** 27.1 (0.1)*,**,*** 
- Adjusteda 27.4 (0.1) 27.0 (0.1)* 28.2 (0.4)*,** 27.1 (0.1)*,*** 
Diabetes cases / Person Years 165 / 9671 207 / 16394 14 / 736 140 / 9792 
HR (95% CI): Model 1 1.07 (0.85-1.35) 0.98 (0.79-1.23) 1.42 (0.81-2.47) 1.00 (ref) 
HR (95% CI): Model 2 1.05 (0.83-1.32) 0.97 (0.78-1.22) 1.39 (0.80-2.43) 1.00 (ref) 
HR (95% CI): Model 3 0.98 (0.78-1.24) 0.96 (0.76-1.20) 1.25 (0.71-2.18) 1.00 (ref) 
     
MORGAM: FINRISK     
N (%) 6410 (32) 3200 (16) 3410 (17) 6739 (34) 
Age, years 41.5 (11.5) 47.3 (12.3) 46.8 (11.8) 44.6 (11.7) 
Men, % 63 26 66 62 
Ethanol consumption, g/day 7.0 [4.0-15.0] 3.0 [2.0-9.0] 8.0 [3.0-14.0] 13.0 [7.0-21.0] 
University or college education, % 9 19 6 15 
Current smokers, % 38 17 34 29 
BMI, kg/m2     
- Crude 25.7 (0.1) 25.9 (0.1)* 25.9 (0.1)*,** 26.2 (0.1)*,**,*** 
- Adjustedaw 25.9 (0.1) 26.1 (0.1) 25.5 (0.1)*,** 26.2 (0.1)*,*** 
Diabetes cases / Person Years 487 / 101570 229 / 50342 437 / 59893 557 / 105820 
HR (95% CI): Model 1 0.98 (0.87-1.11) 0.89 (0.76-1.05) 1.08 (0.95-1.22) 1.00 (ref) 
 
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
HR (95% CI): Model 2 0.97 (0.86-1.10) 0.91 (0.78-1.07) 1.07 (0.94-1.21) 1.00 (ref) 
HR (95% CI): Model 3 1.05 (0.93-1.18) 0.94 (0.80-1.10) 1.00 (0.88-1.13) 1.00 (ref) 
     
MORGAM: Northern-Sweden     
N (%) 794 (26) 511 (17) 146 (5) 1581 (52) 
Age, years 45.5 (13.4) 46.6 (11.6) 49.7 (11.6) 44.3 (11.7) 
Men, %  72 10 81 65 
Ethanol consumption, g/day 2.0 [1.0-6.0] 2.0 [1.0-2.0] 2.0 [1.0-2.0] 4.0 [3.0-6.0] 
University or college education, % 15 26 2 19 
Current smokers, % 23 27 40 30 
BMI, kg/m2     
- Crude 25.4 (0.1) 24.8 (0.2)* 26.7 (0.3)*,**,*** 25.2 (0.1)**,*** 
- Adjusteda 25.2 (0.2) 25.2 (0.2) 26.1 (0.3)*,** 25.2 (0.1)*** 
Diabetes cases / Person Years 40 / 15215 25 / 10413 7 / 2728 77 / 31392 
HR (95% CI): Model 1 0.99 (0.67-1.46) 1.05 (0.63-1.73) 0.88 (0.40-1.93) 1.00 (ref) 
HR (95% CI): Model 2 1.04 (0.71-1.54) 1.10 (0.66-1.83) 0.87 (0.40-1.90) 1.00 (ref) 
HR (95% CI): Model 3 1.06 (0.72-1.56) 1.15 (0.69-1.93) 0.68 (0.31-1.50) 1.00 (ref) 
     
MORGAM: MOLI-SANI     
N (%) 618 (4) 11522 (79) 102 (1) 2268 (16) 
 
Supplemental Table 1 (continued). Selected general characteristics across categories of alcoholic beverage preference and Hazard Ratios (HRs) 
and 95% Confidence Intervals (CIs) of the associations between having a beer, wine, or spirit preference and diabetes incidence compared to 
having no preference in 10 European cohorts based on multiple imputation results. 
 Beer preference Wine preference Spirit preference No preference 
Age, years 49.6 (9.9) 56.7 (11.7) 50.7 (9.3) 49.6 (9.7) 
Men, % 62 60 34 64 
Ethanol consumption, g/day 4.0 [1.0-17.0] 18.0 [10.0-34.0] 2.0 [2.0-7.0] 8.0 [3.0-20.0] 
University or college education, % 13 12 14 17 
Current smokers, % 35 22 25 27 
BMI, kg/m2     
- Crude 27.3 (0.2) 27.8 (0.0)* 26.9 (0.4)** 27.6 (0.1)** 
- Adjusteda  27.7 (0.2) 27.7 (0.0) 27.5 (0.4) 28.0 (0.1)** 
Diabetes cases / Person Years 10 / 2758 255 / 20198 0 / 478 30 / 10319 
HR (95% CI): Model 1 1.21 (0.59-2.49) 1.17 (0.80-1.73) no cases 1.00 (ref) 
HR (95% CI): Model 2  1.19 (0.58-2.44) 1.17 (0.80-1.73) no cases 1.00 (ref) 
HR (95% CI): Model 3 1.29 (0.63-2.65) 1.22 (0.89-1.80) no cases 1.00 (ref) 
* P-value <0.05 versus beer preference; ** P-value <0.05 versus wine preference; *** P-value <0.05 versus spirit preference. 
a BMI adjusted for age, sex, education, employment, prevalent coronary heart disease or cancer, smoking status, sports activity (if available), and 
Healthy Diet Indicator (if available). 
Model 1: Adjusted for age, sex, education, employment, and prevalent coronary heart disease or cancer; 
Model 2: Model 1 additionally adjusted for smoking status, sports activity (if available), and Healthy Diet Indicator score (if available). 
Model 3: Model 2 additionally adjusted for BMI. 
Supplemental Table 2. Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute consumption 
of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
Zutphen Elderly Study Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 185 186 186 557 
Cases / Person Years 14 / 1968 18 / 1903 16 / 2009 48 / 5880 
HR (95% CI): Model 1 1.00 (ref) 1.47 (0.71-3.02) 1.25 (0.60-2.64) 0.98 (0.80-1.20) 
HR (95% CI): Model 2 1.00 (ref) 1.47 (0.71-3.05) 1.30 (0.61-2.77) 0.98 (0.79-1.21) 
HR (95% CI): Model 3 1.00 (ref) 1.47 (0.70-3.07) 1.23 (0.58-2.62) 0.97 (0.77-1.21) 
Wine consumption (residuals)     
N 190 181 186 557 
Cases / Person Years 15 / 1915 14 / 1859 19 / 2106 48 / 5880 
HR (95% CI): Model 1 1.00 (ref) 0.92 (0.44-1.91) 1.25 (0.62-2.52) 0.89 (0.64-1.23) 
HR (95% CI): Model 2 1.00 (ref) 0.93 (0.45-1.95) 1.19 (0.58-2.43) 0.85 (0.60-1.20) 
HR (95% CI): Model 3 1.00 (ref) 0.90 (0.43-1.90) 1.12 (0.55-2.30) 0.84 (0.59-1.21) 
Spirit consumption (residuals)     
N 189 184 184 557 
Cases / Person Years 20 / 2095 13 / 1952 15 / 1833 48 / 5880 
HR (95% CI): Model 1 1.00 (ref) 0.69 (0.34-1.41) 0.77 (0.39-1.54) 1.06 (0.88-1.26) 
HR (95% CI): Model 2 1.00 (ref) 0.73 (0.35-1.50) 0.81 (0.41-1.63) 1.07 (0.89-1.28) 
HR (95% CI): Model 3 1.00 (ref) 0.81 (0.39-1.68) 0.94 (0.47-1.90) 1.08 (0.09-1.31) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
Rotterdam Study Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N (%) 809 815 804 2428 
Cases / Person Years 109 / 8118 112 / 8283 96 / 8042 317 / 24444 
HR (95% CI): Model 1 1.00 (ref) 1.07 (0.82-1.41) 0.88 (0.67-1.17) 0.98 (0.87-1.10) 
HR (95% CI): Model 2 1.00 (ref) 1.08 (0.82-1.42) 0.88 (0.66-1.17) 0.97 (0.86-1.10) 
HR (95% CI): Model 3 1.00 (ref) 1.06 (0.80-1.39) 0.87 (0.62-1.15) 0.97 (0.87-1.09) 
Wine consumption (residuals)     
N (%) 810 819 799 2428 
Cases / Person Years 125 / 7627 99 / 8250 93 / 8567 317 / 24444 
HR (95% CI): Model 1 1.00 (ref) 0.74 (0.55-1.00) 0.67 (0.50-0.90) 0.89 (0.79-1.01) 
HR (95% CI): Model 2 1.00 (ref) 0.74 (0.55-1.00) 0.68 (0.50-0.91) 0.90 (0.79-1.01) 
HR (95% CI): Model 3 1.00 (ref) 0.79 (0.54-0.98) 0.72 (0.54-0.98) 0.92 (0.82-1.04) 
Spirit consumption (residuals)     
N (%) 810 819 799 2428 
Cases / Person Years 89 / 8471 110 / 8359 118 / 7613  317 / 24444 
HR (95% CI): Model 1 1.00 (ref) 1.28 (0.96-1.70) 1.43 (1.08-1.91) 1.09 (0.99-1.19) 
HR (95% CI): Model 2 1.00 (ref) 1.30 (0.97-1.72) 1.41 (1.06-1.87) 1.09 (0.99-1.19) 
HR (95% CI): Model 3 1.00 (ref) 1.26 (0.95-1.68) 1.33 (1.00-1.77) 1.07 (0.98-1.17) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
EPIC-ELDERLY: The Netherlands Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 1264 1265 1264 3793 
Cases / Person Years 67 / 6097 71 / 6120 81 / 6286 219 / 18503 
HR (95% CI): Model 1 1.00 (ref) 1.01 (0.72-1.41) 0.97 (0.69-1.35) 1.07 (0.85-1.36) 
HR (95% CI): Model 2 1.00 (ref) 0.95 (0.67-1.35) 0.96 (0.68-1.35) 1.10 (0.87-1.40) 
HR (95% CI): Model 3 1.00 (ref) 0.79 (0.55-1.14) 0.83 (0.59-1.17) 1.13 (0.89-1.44) 
Wine consumption (residuals)     
N 1265 1264 1264 3793 
Cases / Person Years 78 / 6291 87 / 6172 54 / 6040 219 / 18503 
HR (95% CI): Model 1 1.00 (ref) 1.20 (0.88-1.64) 0.87 (0.61-1.24) 0.90 (0.79-1.03) 
HR (95% CI): Model 2 1.00 (ref) 1.16 (0.84-1.59) 0.85 (0.59-1.22) 0.88 (0.76-1.01) 
HR (95% CI): Model 3 1.00 (ref) 1.03 (0.66-1.37) 0.95 (0.66-1.37) 0.90 (0.78-1.04) 
Spirit consumption (residuals)     
N 1265 1266 1262 3793 
Cases / Person Years 54 / 6068 87 / 6159 78 / 6276 219 / 18503 
HR (95% CI): Model 1 1.00 (ref) 1.43 (1.01-2.02) 1.18 (0.83-1.69) 1.09 (0.95-1.26) 
HR (95% CI): Model 2 1.00 (ref) 1.41 (0.99-2.00) 1.19 (0.83-1.70) 1.12 (0.97-1.29) 
HR (95% CI): Model 3 1.00 (ref) 1.14 (0.79-1.63) 1.04 (0.72-1.49) 1.08 (0.93-1.26) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
EPIC-ELDERLY: Greece Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 1784 1775 1757 5316 
Cases / Person Years 251 / 19614 296 / 19127 268 / 19109 815 / 57849 
HR (95% CI): Model 1 1.00 (ref) 1.48 (1.24-1.76) 1.29 (1.09-1.54) 1.04 (0.96-1.12) 
HR (95% CI): Model 2 1.00 (ref) 1.46 (1.23-1.74) 1.26 (1.06-1.50) 1.02 (0.94-1.10) 
HR (95% CI): Model 3 1.00 (ref) 1.39 (1.17-1.66) 1.20 (1.00-1.43) 1.03 (0.95-1.12) 
Wine consumption (residuals)     
N 1769 1765 1782 5316 
Cases / Person Years 273 / 18828 280 / 19263 262 / 19759 815 / 57849 
HR (95% CI): Model 1 1.00 (ref) 0.84 (0.71-1.00) 0.66 (0.55-0.78) 0.93 (0.88-0.98) 
HR (95% CI): Model 2 1.00 (ref) 0.88 (0.73-1.04) 0.69 (0.58-0.82) 0.94 (0.90-0.99) 
HR (95% CI): Model 3 1.00 (ref) 0.89 (0.63-0.89) 0.75 (0.63-0.89) 0.95 (0.90-1.01) 
Spirit consumption (residuals)     
N 1770 1820 1726 5316 
Cases / Person Years 260 / 19497 284 / 20037 271 / 18315 815 / 57849 
HR (95% CI): Model 1 1.00 (ref) 1.23 (1.03-.46) 1.49 (1.26-1.78) 1.08 (1.02-1.14) 
HR (95% CI): Model 2 1.00 (ref) 1.21 (1.02-1.45) 1.45 (1.22-1.72) 1.06 (1.01-1.12) 
HR (95% CI): Model 3 1.00 (ref) 1.12 (0.94-1.34) 1.35 (1.13-1.61) 1.05 (0.99-1.11) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
EPIC-ELDERLY: Sweden Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 932 949 936 2819 
Cases / Person Years 27 / 12276 48 / 12507 34 / 12400 109 / 37183 
HR (95% CI): Model 1 1.00 (ref) 1.99 (1.22-3.25) 1.14 (0.68-1.91) 0.99 (0.48-2.03) 
HR (95% CI): Model 2 1.00 (ref) 2.02 (1.24-3.31) 1.16 (0.69-1.95) 1.00 (0.48-2.06) 
HR (95% CI): Model 3 1.00 (ref) 1.99 (1.22-3.77) 1.31 (0.78-2.22) 1.20 (0.56-2.56) 
Wine consumption (residuals)     
N 941 921 957 2819 
Cases / Person Years 39 / 12435 43 / 12173 27 / 12576 109 / 37183 
HR (95% CI): Model 1 1.00 (ref) 1.31 (0.83-2.08) 0.85 (0.50-1.45) 0.54 (0.23-1.29) 
HR (95% CI): Model 2 1.00 (ref) 1.32 (0.83-2.10) 0.85 (0.50-1.45) 0.54 (0.23-1.29) 
HR (95% CI): Model 3 1.00 (ref) 1.21 (0.46-1.35) 0.79 (0.46-1.35) 0.44 (0.17-1.10) 
Spirit consumption (residuals)     
N 939 956 924 2819 
Cases / Person Years 21 / 12366 43 / 12604 45 / 12213 109 / 37183 
HR (95% CI): Model 1 1.00 (ref) 2.14 (1.26-3.62) 2.04 (1.21-3.44) 1.76 (0.86-3.61) 
HR (95% CI): Model 2 1.00 (ref) 2.13 (1.26-3.63) 2.02 (1.19-3.43) 1.76 (0.85-3.64) 
HR (95% CI): Model 3 1.00 (ref) 2.05 (1.20-3.49) 1.86 (1.10-3.15) 1.65 (0.74-3.68) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
Tromsø Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 1562 1752 1644 4958 
Cases / Person Years 79 / 20158 97 / 22559 102 / 21103 278 / 63819 
HR (95% CI): Model 1 1.00 (ref) 1.11 (0.82-1.50) 1.07 (0.79-1.45) 1.11 (0.91-1.36) 
HR (95% CI): Model 2 1.00 (ref) 1.11 (0.82-1.50) 1.07 (0.79-1.45) 1.11 (0.91-1.36) 
HR (95% CI): Model 3 1.00 (ref) 1.03 (0.76-1.39) 1.16 (0.85-1.57) 1.16 (0.95-1.41) 
Wine consumption (residuals)     
N 1662 1733 1563 4958 
Cases / Person Years 114 / 20596 100 / 22534 64 / 20689 278 / 63819 
HR (95% CI): Model 1 1.00 (ref) 0.92 (0.70-1.21) 0.70 (0.50-0.97) 0.88 (0.71-1.09) 
HR (95% CI): Model 2 1.00 (ref) 0.92 (0.70-1.22) 0.70 (0.50-0.98) 0.88 (0.71-1.09) 
HR (95% CI): Model 3 1.00 (ref) 0.95 (0.56-1.10) 0.79 (0.56-1.10) 0.91 (0.73-1.15) 
Spirit consumption (residuals)     
N 1708 1617 1633 4958 
Cases / Person Years 80 / 22496 80 / 21103 118 / 20220 278 / 63819 
HR (95% CI): Model 1 1.00 (ref) 1.02 (0.75-1.40) 1.41 (1.05-1.91) 1.07 (0.74-1.54) 
HR (95% CI): Model 2 1.00 (ref) 1.02 (0.75-1.40) 1.41 (1.04-1.92) 1.06 (0.73-1.53) 
HR (95% CI): Model 3 1.00 (ref) 0.85 (0.62-1.16) 1.08 (0.79-1.46) 0.84 (0.57-1.25) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
ESTHER Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 1589 1932 1765 5286 
Cases / Person Years 143 / 11176 186 / 13686 197 / 11731 526 / 36593 
HR (95% CI): Model 1 1.00 (ref) 1.08 (0.86-1.34) 1.12 (0.89-1.40) 1.06 (0.95-1.18) 
HR (95% CI): Model 2 1.00 (ref) 1.10 (0.88-1.37) 1.11 (0.89-1.39) 1.05 (0.95-1.17) 
HR (95% CI): Model 3 1.00 (ref) 1.07 (0.86-1.34) 1.05 (0.84-1.32) 1.05 (0.94-1.16) 
Wine consumption (residuals)     
N 1667 1792 1827 5286 
Cases / Person Years 191 / 11018 175 / 12681 160 / 12894 526 / 36593 
HR (95% CI): Model 1 1.00 (ref) 0.88 (0.71-1.10) 0.83 (0.67-1.04) 0.94 (0.85-1.05) 
HR (95% CI): Model 2 1.00 (ref) 0.90 (0.72-1.13) 0.84 (0.67-1.06) 0.95 (0.85-1.05) 
HR (95% CI): Model 3 1.00 (ref) 0.92 (0.72-1.13) 0.90 (0.72-1.13) 0.96 (0.87-1.07) 
Spirit consumption (residuals)     
N 1865 1834 1687 5286 
Cases / Person Years 166 / 12075 184 / 12834 176 / 11683 526 / 36593 
HR (95% CI): Model 1 1.00 (ref) 1.18 (0.94-1.47) 1.11 (0.89-1.37) 1.06 (0.74-1.53) 
HR (95% CI): Model 2 1.00 (ref) 1.20 (0.96-1.49) 1.12 (0.91-1.39) 1.05 (0.73-1.51) 
HR (95% CI): Model 3 1.00 (ref) 1.12 (0.90-1.39) 1.03 (0.83-1.27) 0.93 (0.64-1.35) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
MORGAM: FINRISK Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 6455 6069 7235 19759 
Cases / Person Years 645 / 103702 493 / 99754 572 / 114169 1710 / 317624 
HR (95% CI): Model 1 1.00 (ref) 0.82 (0.73-0.92) 0.96 (0.86-1.08) 0.97 (0.93-1.02) 
HR (95% CI): Model 2 1.00 (ref) 0.85 (0.75-0.96) 0.96 (0.86-1.07) 0.97 (0.93-1.02) 
HR (95% CI): Model 3 1.00 (ref) 0.95 (0.84-1.07) 1.09 (0.97-1.22) 1.02 (0.98-1.07) 
Wine consumption (residuals)     
N 6643 6477 6639 19759 
Cases / Person Years 705 / 108162 548 / 108167 457 / 101296 1710 / 317624 
HR (95% CI): Model 1 1.00 (ref) 0.81 (0.72-0.91) 0.79 (0.69-0.89) 0.95 (0.88-1.02) 
HR (95% CI): Model 2 1.00 (ref) 0.84 (0.75-0.95) 0.82 (0.72-0.93) 0.96 (0.89-1.02) 
HR (95% CI): Model 3 1.00 (ref) 0.95 (0.78-1.01) 0.89 (0.78-1.01) 0.98 (0.92-1.04) 
Spirit consumption (residuals)     
N 7069 6188 6502 19759 
Cases / Person Years 511 / 105964 445 / 1005545 754 / 111116 1710 / 317624 
HR (95% CI): Model 1 1.00 (ref) 0.81 (0.71-0.92) 1.03 (0.92-1.16) 1.06 (1.01-1.11) 
HR (95% CI): Model 2 1.00 (ref) 0.85 (0.75-0.97) 1.05 (0.94-1.18) 1.05 (1.01-1.10) 
HR (95% CI): Model 3 1.00 (ref) 0.83 (0.73-0.95) 0.92 (0.82-1.03) 0.99 (0.94-1.03) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
MORGAM: MOLI-SANI Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 4811 5065 4634 14510 
Cases / Person Years 110 / 20994 117 / 22226 68 / 20533 295 / 63753 
HR (95% CI): Model 1 1.00 (ref) 1.32 (1.00-1.74) 1.04 (0.76-1.42) 1.04 (0.92-1.18) 
HR (95% CI): Model 2 1.00 (ref) 1.33 (1.00-1.75) 1.04 (0.76-1.42) 1.04 (0.92-1.17) 
HR (95% CI): Model 3 1.00 (ref) 1.26 (0.95-1.66) 1.03 (0.75-1.41) 1.01 (0.90-1.14) 
Wine consumption (residuals)     
N 4797 5271 4442 14510 
Cases / Person Years 75 / 21702 115 / 23140 105 / 18911 295 / 63753 
HR (95% CI): Model 1 1.00 (ref) 1.15 (0.85-1.56) 0.97 (0.71-1.33) 0.98 (0.87-1.10) 
HR (95% CI): Model 2 1.00 (ref) 1.16 (0.85-1.57) 0.97 (0.71-1.33) 0.98 (0.87-1.10) 
HR (95% CI): Model 3 1.00 (ref) 1.14 (0.73-1.36) 1.00 (0.73-1.36) 1.00 (0.89-1.12) 
Spirit consumption (residuals)     
N 4750 5075 4685 14510 
Cases / Person Years 104 / 19857 106 / 22123 85 / 21772 295 / 63753 
HR (95% CI): Model 1 1.00 (ref) 1.23 (0.92-1.64) 1.08 (0.80-1.45) 0.93 (0.68-1.27) 
HR (95% CI): Model 2 1.00 (ref) 1.23 (0.92-1.65) 1.09 (0.81-1.46) 0.93 (0.68-1.27) 
HR (95% CI): Model 3 1.00 (ref) 1.21 (0.91-1.62) 1.02 (0.76-1.37) 0.93 (0.69-1.26) 
  
Supplemental Table 2 (continued). Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) of the associations between residuals of absolute 
consumption of beer, wine, and spirits and diabetes incidence in 10 European cohorts. 
MORGAM: North-Sweden Q1 Q2 Q3 Per 6 g/d 
Beer consumption (residuals)     
N 1101 911 1020 3032 
Cases / Person Years 55 / 21790 44 / 18329 50 / 19628 149 / 59748 
HR (95% CI): Model 1 1.00 (ref) 1.11 (0.74-1.65) 1.04 (0.70-1.55) 1.44 (0.84-2.46) 
HR (95% CI): Model 2 1.00 (ref) 1.15 (0.77-1.73) 1.11 (0.74-1.65) 1.46 (0.87-2.47) 
HR (95% CI): Model 3 1.00 (ref) 1.15 (0.77-1.72) 1.11 (0.75-1.66) 1.49 (0.86-2.60) 
     
Wine consumption (residuals)     
N 784 1224 1024 3032 
Cases / Person Years 40 / 14853 63 / 24261 46 / 20633 149 / 59748 
HR (95% CI): Model 1 1.00 (ref) 0.96 (0.64-1.44) 0.93 (0.58-1.48) 0.87 (0.44-1.69) 
HR (95% CI): Model 2 1.00 (ref) 0.98 (0.65-1.48) 0.92 (0.57-1.48) 0.87 (0.45-1.67) 
HR (95% CI): Model 3 1.00 (ref) 0.99 (0.66-1.68) 1.05 (0.66-1.68) 0.98 (0.49-1.96) 
     
Spirit consumption (residuals)     
N 1042 1012 978 3032 
Cases / Person Years 46 / 20310 47 / 20377 56 / 19060 149 / 59748 
HR (95% CI): Model 1 1.00 (ref) 0.98 (0.65-1.48) 1.09 (0.72-1.65) 0.93 (0.68-1.27) 
HR (95% CI): Model 2 1.00 (ref) 0.99 (0.66-1.50) 1.05 (0.70-1.60) 0.67 (0.29-1.54) 
HR (95% CI): Model 3 1.00 (ref) 0.89 (0.59-1.34) 0.88 (0.58-1.33) 0.51 (0.21-1.26) 
Model 1: Adjusted for age, sex, education, employment, and prevalent coronary heart disease or cancer; 
Model 2: Model 1 additionally adjusted for smoking status, sports activity (if available), and Healthy Diet Indicator score (if available). 
Model 3: Model 2 additionally adjusted for BMI. 
Table 1. Cohort characteristics of the ten included European cohorts from the Consortium on Health and Ageing: Network of Cohorts in Europe 
and the United States (CHANCES) project and number of included persons who reported to consume alcohol. 
Cohort Sub-cohort or 
country 
Baseline 
period 
Follow-
up 
period 
Follow-up 
length, 
median [P25-
P75] 
Ascertainment of incident diabetes type 2 N Age 
category 
Males, 
% 
Zutphen 
Elderly Study 
The 
Netherlands 
1985 1985-
2010 
9.7 [5.0-15.0] Self-report and current treatment and non-
fasting glucose measures using the WHO 
definition46. 
557 ≥60 y 100 
Rotterdam 
Study  
The 
Netherlands 
1990 1997-
2013 
12.2 [7.0-
13.1] 
Followed-up using information from general 
practitioners, pharmacies’ databases, and 
follow-up examinations. Defined as being 
registered by a general practitioner as having 
type 2 diabetes and meeting at least one of 
the following four criteria: fasting plasma 
glucose concentration ≥7.0 mmol/L, random 
plasma glucose concentration ≥11.1 mmol/L, 
use of anti-diabetic mediation, and/or 
following dietary guidelines for type 2 
diabetes. 
2428 ≥55 y 44 
EPIC-Elderly The 
Netherlands 
1993-
1997 
1993-
2005 
4.9 [4.1-5.0] Self-reported diagnosis in the follow-up 
questionnaires and/or a urinary glucose strip 
test for detection of glucosuria, and/or 
linkage with the Dutch register of hospital 
discharge diagnoses47. 
3793 ≥60 y 6 
  
Table 1 (continued). Cohort characteristics of the ten included European cohorts from the Consortium on Health and Ageing: Network of 
Cohorts in Europe and the United States (CHANCES) project and number of included persons who reported to consume alcohol. 
Cohort Sub-cohort or 
country 
Baseline 
period 
Follow-
up 
period 
Follow-up 
length, 
median [P25-
P75] 
Ascertainment of incident diabetes type 2 N Age 
category 
Males, 
% 
 Greece 1994-
1999 
1994-
2011 
11.4 [9.9-
12.5] 
Collected during follow-up through self-
report and current treatment; cases were not 
validated. 
5316 ≥60 y 50 
 Sweden 1992-
1996 
1992-
2011 
13.2 [12.1-
14.2] 
Followed up through linkage with the 
Swedish diabetes register and verified by 
biomarker measurements of impaired 
glucose tolerance and impaired fasting 
glucose in a few cases. 
2819 ≥60 y 51 
The Tromsø 
Study 
Norway 1994-
1995 
1994-
2010 
15.6 [10.0-
16.0] 
Linkage with diabetes-related or 
cardiovascular diseases discharge diagnosis 
at the only hospital serving the Tromsø 
population or verified by self-report or 
observed HbA1c-values >6.5% during 
follow-up. Some of the cases were validated 
using medical records or a non-fasting 
glucose measurement. 
4958 ≥45 y 59 
 
  
Table 1 (continued). Cohort characteristics of the ten included European cohorts from the Consortium on Health and Ageing: Network of 
Cohorts in Europe and the United States (CHANCES) project and number of included persons who reported to consume alcohol. 
Cohort Sub-cohort or 
country 
Baseline 
period 
Follow-
up 
period 
Follow-up 
length, 
median [P25-
P75] 
Ascertainment of incident diabetes type 2 N Age 
category 
Males, 
% 
ESTHER Germany 2000-
2003 
2000-
2007 
7.9 [5.3-8.1] The cohort was systematically searched for 
diabetes events and incident cases were 
validated with medical records during 
follow-up. In addition, subjects with HbA1c 
≥ 6.5% at 8-year follow-up were classified 
as subjects with incident type 2 diabetes in 
order to identify undiagnosed cases. 
5286 48-75 y 53 
MORGAM FINRISK 
(Finland) 
1982-
2002 
1982-
2010 
14.0 [8.9-
23.8] 
Through linkage to the national Hospital 
Discharge Register, Causes of Death 
Register, and drug reimbursement 
registers48. 
19759 24-74 y 57 
 MOLI-SANI 
(Italy) 
2005-
2010 
2005-
2011 
4.3 [3.3-5.4] Cases were identified and validated through 
linkage to the National Medication Register 
and to the Local Diagnosis Registers48. 
14510 35-99 y 60 
 Northern-
Sweden 
(Sweden) 
1986-
1994 
1986-
2011 
20.8 [17.8-
24.5] 
Based on self-reported diagnosis in a phone 
interview and/or linkage with Hospital 
Discharge Records48. 
3032 24-74 y 58 
 
Table 2. Pooled Hazard Ratios (95% CI) from random-effects meta-analyses for the association between having a beer, wine, or spirit preference 
compared to having no preference according to sub-groups and additional analyses. 
 Beer preference Wine preference Spirit preference No preference 
BMI     
‐ <25 kg/m2 1.24 (0.95-1.61) 1.07 (0.85-1.36) 0.89 (0.44-1.82) 1.00 (ref) 
‐ ≥25 kg/m2 1.05 (0.95-1.15) 0.95 (0.85-1.06) 1.26 (1.06-1.51) 1.00 (ref) 
     
Sex     
‐ Men 1.26 (0.93-1.71) 1.17 (0.92-1.50) 1.27 (1.01-1.59) 1.00 (ref) 
‐ Women 1.23 (0.89-1.70) 1.08 (0.85-1.37) 1.33 (1.11-1.60) 1.00 (ref) 
     
Excluding persons with prevalent diseases* 1.04 (0.95-1.15) 0.99 (0.87-1.13) 1.16 (0.95-1.42) 1.00 (ref) 
     
Additional adjustment for frequency pattern 1.05 (0.95-1.16) 0.98 (0.87-1.10) 1.01 (0.90-1.14) 1.00 (ref) 
     
Definition alcoholic beverage preference with cut-off 50% 1.06 (0.93-1.21) 0.93 (0.77-1.12) 1.10 (0.93-1.31) 1.00 (ref) 
* Defined as persons with prevalent heart disease or cancer or a follow-up ≤2 years. 
Models adjusted for age, sex, education, employment, prevalent coronary heart disease or cancer, smoking status, sports activity (if available), 
Healthy Diet Indicator score (if available), and BMI. 
